作者： David Yin

Elippa has been developed in 2013 to develop glass as the substrate antibacterial products. After the domestic authoritative triple hospitals have detected antibacterial effects, they have obtained national patents in the same year. The antibacterial effect can reach 99.99%each time. In 2022, the company's newly applied for vacuum electroplating antiviral technology invention patents have passed the National Patent Office for review and approval.